MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-KL-02-0010841
CML Biotech Limited - healthcare in Aluva, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.33 Cr
▼ 54% YoY
Net loss · FY 2025
₹14.73 Cr
Net margin -60.5%
EBITDA · FY 2025
-₹3.57 Cr
EBITDA margin -14.7%
Authorised capital
₹43.28 Cr
Registered with MCA
Paid-up capital
₹41.5 Cr
Issued & subscribed
Open charges
₹77.67 Cr
Satisfied ₹30.4 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
108
Provident fund records
About CML Biotech Limited
Data last updated:
CML Biotech Limited is a public limited company based in Aluva, Kerala, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 07 April 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL1999PLC012944. Its GSTIN is 32AABCC5927E1Z2 (Kerala). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹43.28 Cr and a paid-up capital of ₹41.5 Cr. It was formerly known as Cml Biotech Private Limited. It is led by directors including Mr Paulose Jacob (Managing Director) and Ashwin Paul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Inkel Business Park, Aluva, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.33 Cr, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹14.73 Cr (net margin -60.5%) and EBITDA of -₹3.57 Cr (EBITDA margin -14.7%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 4% over five years.
The company has about 108 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: CML Biotech. As per MCA filings, the company has open charges of ₹77.67 Cr and satisfied charges of ₹30.4 Cr on record. Court records list 13 cases involving the company, including 5 filed by the company and 8 filed against it; 13 cases are pending. The company has 12 deals on record (5 secondary share transfers, 4 rights issues, 3 funding rounds), with disclosed funding of ₹4.12 Cr; the latest was in November 2023.
CML Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0010841). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cmlbiotech.com.
Company details
CIN U51397KL1999PLC012944
Registration Number 012944
Incorporation Date 07 April 1999
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KL-02-0010841
CIN history
CML Biotech has one previous CIN (Corporate Identification Number): U51397KL1999PTC012944. The current CIN is U51397KL1999PLC012944, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397KL1999PLC012944 | Current |
| U51397KL1999PTC012944 | Previous |
Recognitions & Rankings of CML Biotech
Contact details
CML Biotech Limited's registered office is in Aluva, Kerala. Its website is cmlbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC7 & C8 2nd Floor Tower 2, Inkel Business Park Angamaly South Ernakulam, Aluva, Kerala, India – 683573
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of CML Biotech Limited, buy the company report.
Comprehensive company report
CML Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
CML Biotech operates one associated brand: CML Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Laboratory consumables and equipment are manufactured for life sciences. | cmlbiotech.com |
Business activity
The main business activity of CML Biotech is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
To see the full business activity and turnover split of CML Biotech Limited, buy the company report.
Financials of CML Biotech Limited
FY 2025 filings availableCML Biotech Limited reported revenue of ₹24.33 Cr (down 54% YoY) for FY 2025.
Revenue · FY 2025
₹24.33 Cr ▼ 54%
Net loss · FY 2025
₹14.73 Cr margin -60.5%
EBITDA · FY 2025
-₹3.57 Cr margin -14.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 54%
3 years · compounded
▼ 22%
5 years · compounded
▲ 4%
Revenue fell 54% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹24.33 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.57 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.7% | ||||
| Net Profit Margin | -60.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of CML Biotech Limited, buy the company report.
Board of directors of CML Biotech Limited
CML Biotech has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwin Paul Also directs: Bio Vastum Solutions Private Limited | Director | 22 May 2021 | 5 Years 5 Months | Current |
| Poulose Chaku | Director | 10 Jul 2018 | 8 Years 3 Months | Current |
| Parapully Varkey Joshy Also directs: Astra Bioscience Limited, Bio Vastum Solutions Private Limited | Director | 10 Jul 2018 | 8 Years 3 Months | Current |
| Jessy Poulose Also directs: Astra Bioscience Limited, Ind Dispomed Private Limited | Director | 07 Apr 1999 | 27 Years 6 Months | Current |
| Mr Paulose Jacob Also directs: Astra Bioscience Limited, Ind Dispomed Private Limited | Managing Director | 01 Mar 2006 | 20 Years 7 Months | Current |
Auditor
CML Biotech Limited is audited by Sajive Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sajive Associates | FY 2023 | 003525S |
Shareholding
The shareholding of CML Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of CML Biotech Limited, buy the company report.
Charges & borrowings
Open charges
₹77.67 Cr
Satisfied charges
₹30.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Nov 2023 | 100822121 | Sidbi | ₹3.16 Cr | Open | |
| 27 Nov 2023 | 100817186 | Sidbi | ₹2 Cr | Open | |
| 19 Apr 2023 | 100710062 | Sidbi | ₹1 Cr | Open | |
| 01 Mar 2023 | 100682042 | Sidbi | ₹4.85 Cr | Open | |
| 29 Sep 2022 | 100619877 | Hdfc Bank Limited | ₹15 Cr | Open |
To see the full charge records of CML Biotech Limited, buy the company report.
Total charge records: 29 View all charges
Deals & funding
CML Biotech Limited has 12 deals on record (5 secondary share transfers, 4 rights issues, 3 funding rounds), with disclosed funding of ₹4.12 Cr; the latest was in November 2023.
Total deals
12
Secondary share transfers
5
Rights issues
4
Funding rounds
3
Disclosed funding
₹4.12 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2023 | Rights issue | ₹50 Lakh | Investors: an individual |
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2023 | Rights issue | ₹75 Lakh | Investors: 4 individuals |
| Mar 2021 | Rights issue | ₹2.7 Cr | Investors: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of CML Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
CML Biotech Limited has 13 court cases on record: 5 filed by CML Biotech, 8 filed against it. All cases are pending.
Total cases
13
Filed by the company
5
Filed against the company
8
Pending
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 8 | 13 |
Cases on record (4 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Siemens Financial Services Pvt Ltd | Pending |
| District court, Ernakulam, Kerala | Criminal case | Filed by the company against an individual | Pending |
| District court, Ernakulam, Kerala | Criminal case | Filed by the company against SRV South India Traders | Pending |
| District court, Ernakulam, Kerala | Criminal case | Filed by the company against an individual | Pending |
To see the full case history of CML Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for CML Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
CML Biotech Limited has a workforce of 108 employees on its EPFO records as of Nov 03, 2024, across 1 active EPFO establishment.
Employee count
108
Active EPFO establishments
1
Employee growth
28.57%
GST
CML Biotech has 5 GST registrations: 3 active and 2 cancelled or inactive.
Total GSTINs
5
Active
3
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCC5927E1Z2 | Kerala | Active | 01 Jul 2017 |
| 36AABCC5927E1ZU | Telangana | Active | 01 Jul 2017 |
| 37AABCC5927E1ZS | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of CML Biotech Limited, buy the company report.
Recent activity
CML Biotech Limited has 13 board changes on record since 1999: 5 appointments and 8 cessations. The latest: Sankaranarayanan Ramanathan ceased to be Director on 23 Sep 2024.
AGM
Cml Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 14 Jul 2020 via Charge ID 100352129 with Axis Bank Limited was fully satisfied on 18 Jul 2025.
Charges
A charge with Axis Bank Limited of Rs. 41.08 Cr registered on 27 Sep 2019 with Charge ID 100295689 was modified on 19 Jun 2025.
Filing
Cml Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Sankaranarayanan Ramanathan ceased to be Director.
Ceased
Ajin Anto Madhathiparambil ceased to be Alternate Director.
Ceased
Sumi Joshy ceased to be Alternate Director.
Charges
A charge with Sidbi amounted to Rs. 3.16 Cr with Charge ID 100822121 was registered on 30 Nov 2023.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100817186 was registered on 27 Nov 2023.
Ceased
Bhaskaranpillai Santoshkumar ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 15.00 Cr registered on 29 Sep 2022 with Charge ID 100619877 was modified on 23 May 2023.
Charges
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 100710062 was registered on 19 Apr 2023.
56 earlier events are in the company report.
Frequently asked questions
CML Biotech is an active public limited company based in Aluva, Kerala, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 07 April 1999 (27+ years old) and is registered under CIN U51397KL1999PLC012944.
CML Biotech has 5 current directors:
- Mr Paulose Jacob - Managing Director
- Ashwin Paul - Director
- Poulose Chaku - Director
- Parapully Varkey Joshy - Director
- Jessy Poulose - Director
The latest financial statements of CML Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of CML Biotech is 32AABCC5927E1Z2, registered in Kerala. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 36AABCC5927E1ZU (Telangana), 37AABCC5927E1ZS (Andhra Pradesh).
The CIN (Corporate Identification Number) of CML Biotech is U51397KL1999PLC012944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CML Biotech has 13 court cases on record: 5 filed by the company and 8 filed against it. 13 are pending.
CML Biotech was incorporated on 07 April 1999, making it 27+ years old. It is registered with the Registrar of Companies, Ernakulam.
CML Biotech has 12 deals on record (5 secondary share transfers, 4 rights issues, 3 funding rounds), with disclosed funding of ₹4.12 Cr; the latest was in November 2023.
Sankaranarayanan Ramanathan ceased to be Director on 23 Sep 2024. Ajin Anto Madhathiparambil ceased to be Alternate Director on 18 Mar 2024. Sumi Joshy ceased to be Alternate Director on 18 Mar 2024. CML Biotech has 13 board changes on record in total.
Yes, CML Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-KL-02-0010841).